Pfizer's groundbreaking $3.5 million gene therapy for Hemophilia B just got FDA approval. Here’s what it means for patients ...

Previously approved as a second-line treatment in 2015, following Pfizer’s Xalkori (crizotinib) for metastatic ALK-positive ...

The first-quarter 2024 earnings season is almost over as far as large drugmakers are concerned. Eli Lilly LLY, Novo Nordisk ...

Solvias is building out a 50,000-square-foot facility that will expand its analytical testing services for companies developing cell and gene therapies and ... general manager of U.S. operations, said ...

Regulatory news last week saw the US Food and Drug Administration (FDA) make a land-mark decision to approve the first gene therapies ... Switzerland’s Basilea Pharmaceutica entered into an asset ...

This financial performance reflects the company's robust growth in key areas such as oncology and vaccines. Sales for the ...